Gujarat Themis Biosyn Files SEBI Compliance Certificate for Q1 FY27
Gujarat Themis Biosyn Limited submitted a SEBI compliance certificate for Q1 FY27. Shareholders approved raising funds via Qualified Institutions Placement with 99.98% of polled votes in favor. Total shares polled were 72.96%.
The announcement pertains to a compliance certificate and the outcome of a shareholder vote on a fundraising resolution. While fundraising is important, the announcement itself does not detail the immediate financial impact or the specific amount being raised, making the impact level low.
The announcement is a routine compliance filing and a voting outcome report, which does not inherently indicate positive or negative performance. The voting outcome for fundraising is positive but is presented factually.
Gujarat Themis Biosyn Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 2026. The certificate was received from MUFG lntime India Pvt. Ltd., the company's Registrar and Share Transfer Agent.
The company also provided details regarding voting results for a special resolution concerning raising funds through Qualified Institutions Placement. The total votes polled were 79,496,307 out of 108,965,265 outstanding shares, representing 72.96% of the total. Of these, 79,477,366 votes were in favor, and 18,941 were against, indicating strong shareholder support with 99.98% of polled votes in favor. Promoter and Promoter Group held 77,218,083 shares and all were voted in favor. Public Institutions held 3,221,880 shares, with 1,261,276 votes in favor and 18,630 against. Public - Non Institutions held 28,525,302 shares, with 1,658,349 votes in favor and 311 against.
The resolution for raising funds by issuing Equity Shares through Qualified Institutions Placement was passed as a special resolution. Promoters and promoter groups were not interested in the agenda/resolution.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.